(33-1). Biopharmaceutical Engineering
(33-2). Nanoparticles in Biopharmaceuticals
(33-3). Clinical Trials on Biopharmaceutical Products
(33-4). Drug Disposition & Pharmacokinetics
(33-5). Bioavailability/Bioequivalence on Biopharmaceutical Products
(33-6). Formulation of Biotech Products
(33-7). Novel Approaches in Biopharmaceutics
(33-8). Pharmaceutical Engineering and Drug Delivery Systems
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Steps and strides: Cross-species insights into movement and injury
Babak Faramarzi, Western University of Health Sciences, United States
Title : Eliminating implant failure in humans with nano chemistry: 45,000 cases and counting
Thomas J Webster, Brown University, United States
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico